ONCY:NASDAQ
Oncolytics Biotech Inc
$0.77
arrow_downward
-2.89%(-0.023) 1D
$0.76
arrow_downward
-1.94% (-0.015)bedtimeAfter hours
Closed: Sep 10, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ONCY...
Open
$0.79
High
$0.83
Low
$0.76
Mkt. cap
97.82M
Avg. vol.
700.71K
Volume
0.00
52-wk high
$1.51
52-wk low
$0.73
Beta
1.15
Shares outstanding
127.51M
No. of employees
29
Open
$0.79
High
$0.83
Low
$0.76
Mkt. cap
97.82M
Avg. vol.
700.71K
Volume
0.00
52-wk high
$1.51
52-wk low
$0.73
Beta
1.15
Shares outstanding
127.51M
No. of employees
29
News stories
From web sources and news partners
GuruFocus
·
16 hours ago
Oncolytics (ONCY) Reports Promising Preclinical Data on Pelareor
TipRanks
·
17 hours ago
Oncolytics Biotech Reports Positive Pelareorep Preclinical Results
Investing.com
·
17 hours ago
Oncolytics reports preclinical data on pelareorep with RAS inhibitor
Stock Titan
·
17 hours ago
An experimental cancer treatment combination reduced tumor growth in early tests
Profile
Oncolytics Biotech Inc. is a biotech company headquartered in San Diego, California, that is developing an intravenously delivered immuno-oncolytic virus called pelareorep for the treatment of solid tumors and hematological malignancies. Pelareorep is a non-pathogenic, proprietary isolate of the unmodified reovirus that induces selective tumor lysis and promotes an inflamed tumor phenotype through innate and adaptive immune responses. Wikipedia
About Oncolytics Biotech Inc
CEO-
Employees29
Founded1998
HeadquartersCalgary, Alberta, Canada
SectorBiotechnology
Websiteoncolyticsbiotech.com